Wang Chuan,Li Yanan,Xiang Bo,et al.Measuring reliability and validity of a Chinese mandarin version quality-of-life instrument for infantile hemangioma and its clinical application[J].Journal of Clinical Pediatric Surgery,2019,18(08):635-639,654.[doi:10.3969/j.issn.1671-6353.2019.08.004]
婴幼儿血管瘤生活质量专用量表的信度与效度检验及其临床应用
- Title:
- Measuring reliability and validity of a Chinese mandarin version quality-of-life instrument for infantile hemangioma and its clinical application
- Keywords:
- Hemangioma; Quality of Life; Infant
- 分类号:
- R543;R732.2
- 摘要:
- 目的 国内尚没有评价婴幼儿血管瘤患儿生活质量的专用量表（quality-of-life instrument for IH，IH-QOL）。本研究拟对婴幼儿血管瘤生活质量专用量表中文版的信度与效度进行验证，目的在于评价其在中国人群中的适用性。方法 研究者译制出婴幼儿血管瘤生活质量专用量表中文版，并使用该版本对婴幼儿血管瘤患儿的生活质量进行调查。计算该中文版Cronbach’s α系数，分析其信度与效度，并对影响婴幼儿血管瘤生活质量专用量表评分的因素进行分析。结果 本研究共纳入201例婴幼儿血管瘤。婴幼儿血管瘤生活质量专用量表中文版Cronbach’s α系数为0.766，说明其具有良好的信度和结构效度。多元线性回归分析显示，IH位置和大小是影响IH-QOL总分的影响因素（P<0.05）。IH位置和大小可以解释的变异占总变异的24.7%。回归分析最终模型有统计学意义（F=4.279，P=0.006）。结论 婴幼儿血管瘤生活质量专用量表中文版具有良好的信度与效度，可用于评估我国婴幼儿血管瘤患儿及其父母生活质量。婴幼儿血管瘤瘤体位置及大小是影响其生活质量的因素。
- Abstract:
- Objective Infantile hemangioma (IH) is a common vascular tumor in children.Improving quality-of-life (QOL) in IH children and their family members is a vital target of therapy.The QOL instrument for IH is an IH-specific questionnaire,but its Chinese mandarin version has not been available yet.Thus a Chinese mandarin version QOL instrument for IH was developed for measuring its reliability and validity in Chinese populations.Methods The Chinese mandarin version QOL instrument for IH was administered to the parents of IH children.And Cronbach’s alpha coefficient was calculated.Multivariate linear regression analysis was used for determining the relevant influencing factors of QOL.Results A total of 201 IH children were recruited.The Cronbach’s alpha coefficient for the QOL instrument for IH summary scores was 0.766.The results demonstrated its excellent reliability and structural validity.Multivariate linear regression analysis revealed that two major influencing factors of QOL instrument for IH total scores were size and location of hemangioma.Conclusion The reliability and validity has been confirmed for the Chinese mandarin version of QOL instrument for IH.And hemangioma size and location are important influencing factors of QOL in children with IH and their parents.
参考文献/References:
1 Frieden IJ,Eichenfield LF,Esterly NB,et al.Guidelines of care for hemangiomas of infancy.American Academy of Dermatology Guidelines/Outcomes Committee[J].J Am Acad Dermatol,1997,37(4):631-637.
2 Kilcline C,Frieden IJ.Infantile hemangiomas:How common are they? A systematic review of the medical literature[J].Pediatr Dermatol,2008,25(2):168-173.DOI:10.1111/j.1525-1470.2008.00626.x.
3 Hoornweg MJ,Smeulders MJ.Van der horst CM.Prevalence and characteristics of haemangiomas in young children[J].Ned Tijdschr Geneeskd,2005,149(44):2455-2458.
4 Munden A,Butschek R,Tom WL,et al.Prospective study of infantile haemangiomas:incidence,clinical characteristics and association with placental anomalies[J].B J Dermatol,2014,170(4):907-913.DOI:10.1111/bjd.12804.
5 Chamlin SL,Mancini AJ,Lai J,et al.Development and validation of a Quality-of-Life instrument for infantile hemangiomas[J].J Invest Dermatol,2015,135(6):1533-1539.DOI:10.1038/jid.2015.18.
6 Varni JW,Sherman SA,Burwinkle TM,et al.The PedsQL Family Impact Module:preliminary reliability and validity[J].Health Qual Life Outcomes,2004,2:55.DOI:10.1186/1477-7525-2-55.
7 Chen RQ,Hao YT,Feng LF,et al.The Chinese version of the Pediatric Quality of Life Inventory (TM) (PedsQL (TM)) Family Impact Module:cross-cultural adaptation and psychometric evaluation[J].Health Qual Life Outcomes,2011,910.DOI:10.1186/1477-7525-9-16.
8 Wang C,Li Y,Xiang B,et al.Quality of Life in children with infantile hemangioma:a case control study[J].Health Qual Life Outcomes,2017,15(1):10.DOI:10.1186/s12955-017-0772-z.
9 Wojcicki P,Wojcicka K.Epidemiology,diagnostics and treatment of vascular tumours and malformations[J].Adv Clin Exp Med,2014,23(3):475-484.DOI:10.17219/acem/37149.
10 祝秀丹,葛莉.心得安治疗婴儿血管瘤相关研究进展[J].临床小儿外科杂志,2012,11(06):475-476.DOI:10.3969/j.issn.1671-6353.2012.06.026.Zhu XD,Ge L.Update of research on infantile hemangiomas treated with propanolol[J].J Clin Ped Sur,2012,11(06):475-476.DOI:10.3969/j.issn.1671-6353.2012.06.026.
11 Leaute-Labreze C,Hoeger P,Mazereeuw-Hautier J,et al.A randomized,controlled trial of oral propranolol in infantile hemangioma[J].N Engl J Med,2015,372(8):735-746.DOI:10.1056/NEJMoa1404710.
12 Prey S,Voisard JJ,Delarue A,et al.Safety of propranolol therapy for severe infantile hemangioma[J].JAMA,2016,315(4):413-415.
13 Lawley LP,Siegfried E,Todd JL.Propranolol treatment for hemangioma of infancy:risks and recommendations[J].Pediatr Dermatol,2009,26(5):610-614.DOI:10.1111/j.1525-1470.2009.00975.x.
14 Janmohamed SR,Van Oosterhout M,De Laat PC,et al.Scoring the therapeutic effects of oral propranolol for infantile hemangioma:A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS)[J].J Am Acad Dermatol,2015,73(2):258-263.DOI:10.1016/j.jaad.2015.05.012.
15 Haggstrom AN,Beaumont JL,Lai J,et al.Measuring the severity of infantile hemangiomas instrument development and reliability[J].Arch Dermatol,2012,148(2):197-202.DOI:10.1001/archdermatol.2011.926.
16 Ji Y,Wang Q,Chen SY,et al.Oral atenolol therapy for proliferating infantile hemangioma A prospective study[J].Medicine (Baltimore),2016,95(24):554-560.DOI:10.1097/MD.0000000000003908.
17 Liu LS,Sokoloff D,Antaya RJ.Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas-is it indicated?[J].Pediatr Dermatol,2013,30(5):554-560.DOI:10.1111/pde.12182.
18 Hoornweg MJ,Grootenhuis MA,van der Horst CM.Health-related quality of life and impact of haemangiomas on children and their parents[J].J Plast Reconstr Aesthet Surg,2009,62(10):1265-1271.DOI:10.1016/j.bjps.2008.03.021.
19 Zweegers J,van der Vleuten CJ.The psychosocial impact of an infantile haemangioma on children and their parents[J].Arch Dis Child,2012,97(10):922-926.DOI:10.1136/archdischild-2012-302470.
20 Bauland CG,Luning TH,Smit JM,et al.Untreated hemangiomas:growth pattern and residual lesions[J].Plast Reconstr Surg,2011,127(4):1643-1648.DOI:10.1097/PRS.0b013e318208d2ac.
21 Haggstrom AN,Drolet BA,Baselga E,et al.Prospective study of infantile hemangiomas:clinical characteristics predicting complications and treatment[J].Pediatrics,2006,118(3):882-887.DOI:10.1542/peds.2006-0413.
22 Xu GQ,Lv RR,Zhao ZF,et al.Topical propranolol for treatment of superficial infantile hemangiomas[J].J Am Acad Dermatol,2012,67(6):1210-1213.DOI:10.1016/j.jaad.2012.03.009.
23 Chan H,Mckay C,Adams S,et al.RCT of timolol maleate gel for superficial infantile hemangiomas in 5-to 24-Week-Olds[J].Pediatrics,2013,131(6):1739-1747.DOI:10.1542/peds.2012-3828.
24 Puttgen K,Lucky A,Adams D,et al.Topical timolol maleate treatment of infantile hemangiomas[J].Pediatrics,2016,138(3):e20160355.DOI:10.1542/peds.2016-0355.
相似文献/References:
[1]周启星,杨文,成琦,等.婴儿腮腺血管瘤22例[J].临床小儿外科杂志,2007,6(03):17.
[2]杨恩 刘铭 彭强. 血管瘤血管内皮生长因子受体KDR基因异常甲基化的研究[J].临床小儿外科杂志,2012,11(04):268.
[J].Journal of Clinical Pediatric Surgery,2012,11(08):268.
[3]徐仙赟 谢琼珺 黄海金. 噻吗洛尔和普萘洛尔体外调控小鼠血管瘤细胞增殖及凋亡作用的比较[J].临床小儿外科杂志,2014,13(02):117.
[4]黄文雅 肖 天 李春旺 邓 敏 金 科.血管瘤并血小板减少综合征介入栓塞治疗的效果分析[J].临床小儿外科杂志,2018,17(01):43.
Huang Wenya,Xiao Tian,Li Chunwang,et al.Interventional treatment for KasabachMerrit syndrome in children:a report of 7 cases.[J].Journal of Clinical Pediatric Surgery,2018,17(08):43.
[5]高石,赵国强,岳晓洁.儿童指端血管球瘤1例报道并文献复习[J].临床小儿外科杂志,2019,18(07):615.[doi:10.3969/j.issn.1671-6353.2019.07.019]
Gao Shi,Zhao Guoqiang,Yue Xiaojie.A case report of a fingertip glomus tumor in children and literature review[J].Journal of Clinical Pediatric Surgery,2019,18(08):615.[doi:10.3969/j.issn.1671-6353.2019.07.019]
[6]刘文英.脉管异常类疾病的分类及相关临床问题[J].临床小儿外科杂志,2019,18(08):621.[doi:10.3969/j.issn.1671-6353.2019.08.001]
Liu Wenying.Classifications and clinical managements of vascular abnormalities[J].Journal of Clinical Pediatric Surgery,2019,18(08):621.[doi:10.3969/j.issn.1671-6353.2019.08.001]
[7]张明,彭强,刘铭.NF-κB因子在普萘洛尔治疗裸鼠血管瘤模型过程中的表达[J].临床小儿外科杂志,2019,18(08):655.[doi:10.3969/j.issn.1671-6353.2019.08.008]
Zhang Ming,Peng Qiang,Liu Ming.Expression of NF-kappa B in propranolol treatment for infantile hemangioma in nude mice model[J].Journal of Clinical Pediatric Surgery,2019,18(08):655.[doi:10.3969/j.issn.1671-6353.2019.08.008]
[8]树叶,黄文雅,罗勇奇,等.10例婴幼儿卡梅综合征临床特征及治疗经验总结[J].临床小儿外科杂志,2019,18(09):775.[doi:10.3969/j.issn.1671-6353.2019.09.014]
Shu Ye,Huang Wenya,Luo Yongqi,et al.Summary of clinical features and treatment protocols of 10 infants with Kasabach-Merritt syndrome[J].Journal of Clinical Pediatric Surgery,2019,18(08):775.[doi:10.3969/j.issn.1671-6353.2019.09.014]
[9]王长凤,孙佳丽,吴长华,等.595 nm脉冲染料激光联合噻吗洛尔滴眼液治疗浅表性婴幼儿血管瘤的疗效观察[J].临床小儿外科杂志,2019,18(11):953.[doi:10.3969/j.issn.1671—6353.2019.11.011]
Wang Changfeng,Sun Jiali,Wu Changhua,et al.Curative efficacy of timolol plus 595nm pulsed dye laser for superficial infantile hemangioma[J].Journal of Clinical Pediatric Surgery,2019,18(08):953.[doi:10.3969/j.issn.1671—6353.2019.11.011]
[10]郑珊.胆道闭锁患儿获得长期生存需要关注的问题[J].临床小儿外科杂志,2020,19(06):469.[doi:10.3969/j.issn.1671-6353.2020.06.001]
Zheng Shan.Several outstanding issues in long-term survival of children with biliary atresia[J].Journal of Clinical Pediatric Surgery,2020,19(08):469.[doi:10.3969/j.issn.1671-6353.2020.06.001]
备注/Memo
收稿日期:2018-03-11。
基金项目:国家自然科学基金（编号：81401606）；四川大学优秀青年学者基金（编号：2015SU04A15）
通讯作者:吉毅,Email:jijiyuanyuan@163.com